dose was 43 (32-48) Gary equivalents (GyE) and no severe complication (>grade II) was recorded. After the median follow-up period after CIRT was 77 months (range, 29-130 months), the Kaplan-Meier estimate of overall survival or disease-specific survival after the CIRT showed that the 5-year survival rate was 78.6% or 92.9%, respectively. 
Background and Aims: To study the prognostic value for overall survival (OS) of the self-reported health-related quality of life (HRQOL) at diagnosis in very elderly patients with advanced non-small-cell lung cancer (NSCLC).
Methods: From 2014 to 2017, we retrospectively reviewed the prospective lung cancer database of 8 Hospitals of the college of medicine, the Catholic University of Korea. We included 112 patients aged ≥75 with advanced NSCLC and evaluated quality of life by using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 at diagnosis to investigate the prognostic value of HRQOL for OS. Also, the presence of comorbidity was assessed and summarized using the Charlson comorbidity index. The Cox proportional hazards modelling was used for analysis of survival. Statistical analysis was performed with SPSS version 25 and survival package of R version 3.3.3
Results: The final multivariate Cox regression model retained nine parameters as independent prognostic factors for survival. In HRQOL, global health status score(25~50 to 75~100) with a hazard ratio(HR) = 2.085(95% P = 0.0257); role function(50~100 to 0~50) with HR 0.203(95% P = 0.0004); cognitive function(0~50 to 50~100) with HR 10.139(95% P = 0.0003). In clinical parameters, CCI(3 to 1) with HR 0.163(95% P = 0.0053); male gender with HR 2.089(95% P = 0.0701); Age(85< to ≤85) with HR 6.384(95% P = 0.0001); chemotherapy group with HR 0.2465 to palliative group(95% P<0.0000); stage(4 to 3) with HR 2.465(95% P = 0.0098). And in pathology, squamous cell carcinoma with HR 0.179(95% P = 0.0202) and adenocarcinoma with HR 0.077(95% P = 0.0011) to other pathologies.
Conclusion:
The results suggest that patients' self-reported HRQOL at diagnosis provide independent prognostic information for survival in very elderly patients with advanced non-small-cell lung cancer. This findings support that the collection of HRQOL is important in clinical practice with very old age patients. Background and Aims: Although the underlying specific mechanism still needs to be elucidated, reactive oxygen species have considerable effect on various features of malignant tumours. Hence, serum oxidative stress level has been recognized as a significant risk factor for poor clinical outcome. Because epigenetic gene silencing through DNA methylation has a significant role in progression of diverse human cancers, the aim of this study was to investigate whether serum oxidative stress level is associated with DNA methylation profile in preoperatively collected peripheral whole blood samples from patients with curatively resected node-negative lung adenocarcinoma.
Methods: Forty-five patients who had been subjected to curative resection for pathological Stage I lung adenocarcinoma were enrolled in this study. Serum reactive oxygen metabolite (ROM) levels were measured. Methylation-specific PCR analysis was performed to determine the DNA methylation status of 12 genes (RARB, MDFI, HOXD11, SIM-1, PCDH10, GDNF, Rec8p, HS3ST2, DCC, miRNA137, KLK10, TIMP3) in peripheral whole blood samples collected preoperatively. The clinical relevance of the methylation profile and serum ROM level to the outcome of the disease was evaluated.
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